Combined thrombophilic mutations in women with unexplained recurrent miscarriage

American Journal of Reproductive Immunology

Volumn 57, Issue 2, 2007, Pages 133-141

  Sotiriadis, Alexandros ^a   Vartholomatos, George ^a   Pavlou, Matthaios ^a   Kolaitis, Nicolaos ^a   Dova, Leucothea ^a   Stefos, Theodor ^a   Paraskevaidis, Evangelos ^a   Kalantaridou, Sophia N ^a  

^a UNIVERSITY HOSPITAL OF IOANNINA   (Greece)

Author keywords

Factor V; MTHFR; Pregnancy; Prothrombin

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); ALANINE; BLOOD CLOTTING FACTOR 5; BLOOD CLOTTING FACTOR 5 LEIDEN; CYSTEINE; GLYCINE; HISTIDINE; PROTHROMBIN; THREONINE;

ADULT; AMINO ACID SUBSTITUTION; ARTICLE; CONTROLLED STUDY; FEMALE; GENE MUTATION; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC HETEROGENEITY; GESTATIONAL AGE; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; POLYMERASE CHAIN REACTION; PREVALENCE; PRIORITY JOURNAL; RECURRENCE RISK; RECURRENT ABORTION; RISK ASSESSMENT; SAMPLE SIZE; STATISTICAL SIGNIFICANCE; THROMBOPHILIA;

ABORTION, HABITUAL; ADULT; CASE-CONTROL STUDIES; FACTOR V; FEMALE; HUMANS; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); MUTATION; POLYMERASE CHAIN REACTION; PREGNANCY; PROTHROMBIN; THROMBOPHILIA;

EID: 33846249170     PISSN: 10467408     EISSN: 16000897     Source Type: Journal    
DOI: 10.1111/j.1600-0897.2006.00454.x     Document Type: Article

References (34)

1. Robertson L, Wu O, Langhorne P, Twaddle S, Clark P, Lowe GD, Walker ID, Greaves M, Brenkel I, Aegan L, Greer IA: Thrombophilia in pregnancy: a systematic review. Br J Haematol 2006; 132: 171-196.
2. Hoekema L, Castoldi E, Tans G, Girelli D, Gemmati D, Bernardi F, Rosing J: Functional properties of factor V and factor Va encoded by the R2-gene. Thromb Haemost 2001; 85: 75-81.
3. Doggen CJ, de Visser MC, Vos HL, Bertina RM, Cats VM, Rosendaal FR: The HR2 haplotype of factor V is not associated with the risk of myocardial infarction. Thromb Haemost 2000; 84: 815-818.
4. Akar N, Yilmaz E, Akar E, Deda G, Sipahi T: Factor V (His 1299 Arg) in young Turkish patients with cerebral infarct. Haemostasis 2000; 30: 118-122.
5. Alhenc-Gelas M, Nicaud V, Gandrille S, van DP, Amiral J, Aubry ML, Fiessinger JN, Emmerich J, Aiach M: The factor V gene A4070G mutation and the risk of venous thrombosis. Thromb Haemost 1999; 81: 193-197.
6. Weisberg I, Tran P, Christensen B, Sibani S, Rozen R: A second genetic polymorphism in methylenetetrahydrofolate reductase (MTHFR) associated with decreased enzyme activity. Mol Genet Metab 1998; 64: 169-172.
7. Friedman G, Goldschmidt N, Friedlander Y, Ben-Yehuda A, Selhub J, Babaey S, Mendel M, Kidron M, Bar-On H: A common mutation A1298C in human methylenetetrahydrofolate reductase gene: Association with plasma total homocysteine and folate concentrations. J Nutr 1999; 129: 1656-1661.
8. Zetterberg H, Regland B, Palmer M, Ricksten A, Palmqvist L, Rymo L, Arvanitis DA, Spandidos DA, Blennow K: Increased frequency of combined methylenetetrahydrofolate reductase C677T and A1298C mutated alleles in spontaneously aborted embryos. Eur J Hum Genet 2002; 10: 113-118.
9. Dossenbach-Glaninger A, van TM, Dossenbach M, Oberkanins C, Moritz A, Krugluger W, Huber J, Hopmeier P: Plasminogen activator inhibitor 1 4G/ 5G polymorphism and coagulation factor XIII Val34Leu polymorphism: impaired fibrinolysis and early pregnancy loss. Clin Chem 2003; 49: 1081-1086.
10. Hohlagschwandtner M, Unfried G, Heinze G, Huber JC, Nagele F, Tempfer C: Combined thrombophilic polymorphisms in women with idiopathic recurrent miscarriage. Fertil Steril 2003; 79: 1141-1148.
11. Coulam CB, Jeyendran RS, Fishel LA, Roussev R: Multiple thrombophilic gene mutations rather than specific gene mutations are risk factors for recurrent miscarriage. Am J Reprod Immunol 2006; 55: 360-368.
12. Preston FE, Rosendaal FR, Walker ID, Briet E, Berntorp E, Conard J, Fontcuberta J, Makris M, Mariani G, Noteboom W, Pabinger I, Legnani C, Scharrer I, Schulman S, van der Meer FJ: Increased fetal loss in women with heritable thrombophilia. Lancet 1996; 348: 913-916.
13. Zoller B, Svensson PJ, He X, Dahlback B: Identification of the same factor V gene mutation in 47 out of 50 thrombosis-prone families with inherited resistance to activated protein C. J Clin Invest 1994; 94: 2521-2524.
14. Poort SR, Rosendaal FR, Reitsma PH, Bertina RM: A common genetic variation in the 3′-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood 1996; 88: 3698-3703.
15. Frosst P, Blom HJ, Milos R, Goyette P, Sheppard CA, Matthews RG, Boers GJ, den HM, Kluijtmans LA, van den Heuvel LP: A candidate genetic risk factor for vascular disease: A common mutation in methylenetetrahydrofolate reductase. Nat Genet 1995; 10: 111-113.
16. Pecheniuk NM, Morris CP, Walsh TP, Marsh NA: The factor V HR2 haplotype: prevalence and association of the A4070G and A6755G polymorphisms. Blood Coagul Fibrinolysis 2001; 12: 201-206.
17. Isotalo PA, Donnelly JG: Prevalence of methylenetetrahydrofolate reductase mutations in patients with venous thrombosis. Mol Diagn 2000; 5: 59-66.
18. Hardy G: Mendelian proportions in a mixed population. Science 1908; 28: 49-50.
19. Rey E, Kahn SR, David M, Shrier I: Thrombophilic disorders and fetal loss: A meta-analysis. Lancet 2003; 361: 901-908.
20. Foka ZJ, Lambropoulos AF, Saravelos H, Karas GB, Karavida A, Agorastos T, Zournatzi V, Makris PE, Bontis J, Kotsis A: Factor V leiden and prothrombin G20210A mutations, but not methylenetetrahydrofolate reductase C677T, are associated with recurrent miscarriages. Hum Reprod 2000; 15: 458-462.
21. Ioannou HV, Mitsis M, Eleftheriou A, Matsagas M, Nousias V, Rigopoulos C, Vartholomatos G, Kappas AM: The prevalence of factor V Leiden as a risk factor for venous thromboembolism in the population of North-Western Greece. Int Angiol 2000; 19: 314-318.
22. Zalavras C, Giotopoulou S, Dokou E, Mitsis M, Ioannou HV, Tsaousi C, Tzolou A, Kolaitis N, Vartholomatos G: Prevalence of the G20210A prothrombin gene mutation in Northwestern Greece and association with venous thromboembolism. Int Angiol 2003; 22: 55-57.
23. Zalavras C, Giotopoulou S, Dokou E, Mitsis M, Ioannou HV, Tzolou A, Kolaitis N, Vartholomatos G: Lack of association between the C677T mutation in the 5,10-methylenetetrahydrofolate reductase gene and venous thromboembolism in Northwestern Greece. Int Angiol 2002; 21: 268-271.
24. Jauniaux E, Hempstock J, Greenwold N, Burton GJ: Trophoblastic oxidative stress in relation to temporal and regional differences in maternal placental blood flow in normal and abnormal early pregnancies. Am J Pathol 2003; 162: 115-125.
25. Sebire NJ, Fox H, Backos M, Rai R, Paterson C, Regan L: Defective endovascular trophoblast invasion in primary antiphospholipid antibody syndrome-associated early pregnancy failure. Hum Reprod 2002; 17: 1067-1071.
26. Gopel W, Ludwig M, Junge AK, Kohlmann T, Diedrich K, Moller J: Selection pressure for the factor-V-Leiden mutation and embryo implantation. Lancet 2001; 358: 1238-1239.
27. Sano T, Gabazza EC, Zhou H, Takeya H, Hayashi T, Ido M, Adachi Y, Uchida A, Suzuki K: The zymogen prothrombin stimulates cell locomotion and calcium influx in murine osteosarcoma cells by different mechanism from thrombin. Int J Oncol 1999; 15: 1197-1203.
28. Henrikson KP, Salazar SL, Fenton JW, Pentecost BT: Role of thrombin receptor in breast cancer invasiveness. Br J Cancer 1999; 79: 401-406.
29. Rodriguez-Nieto S, Chavarria T, Martinez-Poveda B, Sanchez-Jimenez F, Rodriguez QA, Medina MA: Anti-angiogenic effects of homocysteine on cultured endothelial cells. Biochem Biophys Res Commun 2002; 293: 497-500.
30. Martinez-Poveda B, Chavarria T, Sanchez-Jimenez F, Quesada AR, Medina MA: An in vitro evaluation of the effects of homocysteine thiolactone on key steps of angiogenesis and tumor invasion. Biochem Biophys Res Commun 2003; 311: 649-653.
31. Brigham SA, Conlon C, Farquharson RG: A longitudinal study of pregnancy outcome following idiopathic recurrent miscarriage. Hum Reprod 1999; 14: 2868-2871.
32. Benson JM, Ellingsen D, El-Jamil M, Jenkins M, Miller CH, Dilley A, Evatt BL, Hooper WC: Factor V Leiden and factor V R2 allele: high-throughput analysis and association with venous thromboembolism. Thromb Haemost 2001; 86: 1188-1192.
33. Kostka H, Schwarz T, Schellong S, Mix C, Kuhlisch E, Temelkova-Kurktschiev T, Henkel E, Kohler C, Gehrisch S, Siegert G: Coagulation factor V G allele and HR2 haplotype: Factor V activity, activated protein C resistance and risk of venous thrombosis. Blood Coagul Fibrinolysis 2003; 14: 49-56.
34. Rady PL, Tyring SK, Hudnall SD, Vargas T, Kellner LH, Nitowsky H, Matalon RK: Methylenetetrahydrofolate rTductase (MTHFR): the incidence of mutations C677T and A1298C in the Ashkenazi Jewish population. Am J Med Genet 1999; 86: 380-384.